NUVB FY 2022 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena

NUVBNuvation Bio Inc.

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$120M

Net Income

-$104M

EPS (Diluted)

$-0.48

Cash Flow

Operating Cash Flow

-$96M

Free Cash Flow

-$96M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$672M

Total Liabilities

$17M

Stockholders' Equity

$655M

Cash & Equivalents

$101M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$120M	-$93M	-28.3%
Net Income	-$104M	-$87M	-20.0%